Zobrazeno 1 - 10
of 1 122
pro vyhledávání: ''
Autor:
Vivian E, Saper, Michael J, Ombrello, Adriana H, Tremoulet, Gonzalo, Montero-Martin, Sampath, Prahalad, Scott, Canna, Chisato, Shimizu, Gail, Deutsch, Serena Y, Tan, Elaine F, Remmers, Dimitri, Monos, Timothy, Hahn, Omkar K, Phadke, Elaine, Cassidy, Ian, Ferguson, Vamsee, Mallajosyula, Jianpeng, Xu, Jaime S, Rosa Duque, Gilbert T, Chua, Debopam, Ghosh, Ann Marie, Szymanski, Danielle, Rubin, Jane C, Burns, Lu, Tian, Marcelo A, Fernandez-Vina, Elizabeth D, Mellins, Jill A, Hollenbach, Claudio, Len
Publikováno v:
Annals of the Rheumatic Diseases. 81:406-415
ObjectivesDrug reaction with eosinophilia and systemic symptoms (DRESS) is a severe, delayed hypersensitivity reaction (DHR). We observed DRESS to inhibitors of interleukin 1 (IL-1) or IL-6 in a small group of patients with Still’s disease with aty
Autor:
Varun Dhir, Shefali Khanna Sharma, Amita Aggarwal, Siddharth Jain, Aastha Khullar, Bidyalaxmi Leishangthem, Supriya Maurya, Ranjan Gupta, Aman Sharma, Sanjay Jain, Shankar Naidu, Veena Dhawan
Publikováno v:
Annals of the Rheumatic Diseases. 80:1376-1384
ObjectivesThere are no head-to-head trials of different dose escalation strategies of methotrexate (MTX) in RA. We compared the efficacy, safety and tolerability of ‘usual’ (5 mg every 4 weeks) versus ‘fast’ (5 mg every 2 weeks) escalation of
Autor:
Yoshihiko Sakurai, Satoshi Okada, Masato Yashiro, Nami Okamoto, Tomoko Matsuda, Hiroshi Fujii, Ryuta Nishikomori, Yuzaburo Inoue, Ikuo Okafuji, Naotomo Kambe, Yoko Ueki, Utako Kaneko, Masami Inoue, Mototsugu Doi, Naoki Kato, Nobuo Kanazawa, Hiroko Kobayashi, Junichi Hosokawa, Ichiro Kobayashi, Shuichi Ito, Syuji Takei, Kyoko Tonomura, Yasuhiro Kondo, Yoshikazu Otsubo, Atsushi Kawakami, Kazushi Izawa, Megumu K. Saito, Naomi Iwata, Teruhiko Makino, Osamu Ohara, Yuta Maruyama, Yoshitaka Honda, Shusaku Ito
Publikováno v:
Annals of the Rheumatic Diseases. 79:1492-1499
ObjectivesTo collect clinical information and NOD2 mutation data on patients with Blau syndrome and to evaluate their prognosis.MethodsFifty patients with NOD2 mutations were analysed. The activity of each NOD2 mutant was evaluated in HEK293 cells by
Autor:
Camille P. Figueiredo, Georg Schett, Stephanie Finzel, Juergen Rech, Adrian P. Regensburger, Sebastian Krauß, Roland Kocijan
Publikováno v:
Annals of the Rheumatic Diseases. 78:1186-1191
ObjectiveTo compare the effects of interleukin-6 (IL-6) receptor and tumour necrosis factor inhibition on inducing repair of existing bone erosions in patients with very early rheumatoid arthritis (RA).MethodsProspective non-randomised observational
Autor:
Lucas L van den Hoogen, Joel A G van Roon, Judith Wienke, Marzia Rossato, Femke van Wijk, Ruth D E Fritsch-Stork, Catharina G.K. Wichers, Jorre S. Mertens, Aridaman Pandit, Timothy R D J Radstake, Ana P Lopes, Wilco de Jager
Publikováno v:
Annals of the Rheumatic Diseases. 77:1810-1814
ObjectiveThe interferon (IFN) signature is related to disease activity and vascular disease in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) and represents a promising therapeutic target. Quantification of the IFN signature i
Autor:
Dimitrios I. Fotiadis, V. Pezoulas, G. Tsourouflis, L. Chatzis, Clio P. Mavragani, Haralampos M. Moutsopoulos, A. G. Tzioufas, M. Voulgarelis, Andreas V. Goules, Ioanna E Stergiou
Publikováno v:
Annals of the Rheumatic Diseases. 80:180-181
Background:Sjögren’s Syndrome (SS) is a chronic systemic autoimmune disease of unknown etiology, carrying the highest lymphoma risk among autoimmune diseases, with significant impact on mortality and morbidity of patients.Objectives:To describe: i
Autor:
Catherine Bakewell, D. McGonagle, X. Meng, P.G. Conaghan, Philippe Goupille, Georg Schett, B. Parikh, Frank Behrens, Corine Gaillez, Gurjit S. Kaeley
Publikováno v:
Annals of the Rheumatic Diseases. 80:311-312
Background:Enthesitis is a key musculoskeletal manifestation of psoriatic arthritis (PsA). EULAR guidelines recommend biologics for patients with enthesitis and an inadequate response to or intolerance of nonsteroidal anti-inflammatory drugs, althoug
Publikováno v:
Annals of the Rheumatic Diseases. 80:1310-1311
Background:Patients with psoriatic arthritis (PsA) in moderate disease activity (ModDA) who are naive to disease-modifying antirheumatic drugs (DMARDs) have a higher probability of achieving the Clinical Disease Activity Index for PsA (cDAPSA) treatm
Autor:
Francesco Benvenuti, Roberto Gerli, Giacomo Emmi, A. De Paulis, Andrea Doria, Luca Moroni, Giacomo Tanti, Mariele Gatto, Giovanni Orsolini, Marta Mosca, Giuseppe A. Ramirez, Giulia Pazzola, Paolo Cardinaletti, Fulvia Ceccarelli, Salvatore Scarpato, Margherita Zen, Serena Fasano, Alessandra Bortoluzzi, G. De Marchi, E. Bartoloni Bocci, Franco Franceschini, Antonella Laria, Paola Faggioli, Armando Gabrielli, Enrica Bozzolo, M. Fredi, Marcello Govoni, T. Ubiali, Carlo Salvarani, Chiara Tani, Angela Tincani, Francesca Saccon, Francesca Regola, Maria Gerosa, Fabrizio Conti, Elisa Gremese, Maurizio Rossini, Enrico Brunetta, S. De Vita, Luca Iaccarino, Francesco Ciccia
Publikováno v:
Annals of the Rheumatic Diseases. 80:594-595
Background:LN is still a severe manifestation of Systemic lupus erythematosus (SLE) and multitarget therapy is needed to control the disease especially in refractory cases.Objectives:To evaluate renal response in SLE patients with glomerulonephritis
Publikováno v:
Annals of the Rheumatic Diseases. 80:336-337
Background:COMPLETE-AS was a Canadian observational study among biologic-naïve adults with active ankylosing spondylitis (AS) initiated on either adalimumab (ADA) or subsequent non-biologic disease-modifying anti-rheumatic drugs and/or non-steroidal